Navigation Links
Daily Sun Exposure and Vitamin D Intake Simplified With Wearable Device

Portland, OR (PRWEB) August 07, 2014

Ultra has introduced the first-ever wearable technology that measures an individual’s accumulated ultraviolet (UV) dosage and effective vitamin D generation. Violet pairs with a mobile device to provide real-time data on overall sun exposure.

Ultra serves health conscious individuals who are concerned about the detrimental effects of sun over-exposure (i.e. skin aging and skin cancer), as well as the risks of under-exposure, including vitamin D deficiency and depression. The device has been available for pre-order on Kickstarter for 30 days beginning July 21.

“Ultra has created an outstanding device with unique solutions relevant to a growing population of health conscious individuals concerning the important health effects of both UV over-exposure and vitamin D deficiency,” said Dr. Andrew Blauvelt, M.D., M.B.A., dermatologist and President of the Oregon Medical Research Center. “There is no similar product on the market. Violet is the only device capable of capturing both UV exposure and vitamin D production data, and personalizing them to achieve balance for each end user.”

Violet helps people achieve optimal balance of sun exposure to maintain personal health. The device can be worn on a wrist, attached to an article of clothing or simply set within close proximity of the user. Violet syncs to a mobile device (Android or iPhone). Each device can be configured for multiple users with personalized settings.

According to Wall Street Journal’s May 2014 MarketWatch, the $3 billion global wearable computing market is expected to grow at a compound annual growth rate of 43.4 percent with more than $30.2 billion forecast for 2018.

The Ultra team includes seasoned entrepreneurs, industry-leading electrical engineers, software developers, biomedical researchers, a world-renowned dermatologist and expert user interface/experience designers. Ultra practices lean methodologies to ensure products are developed with world-class, human-centered design principles. Design is at the core of Ultra’s development process.

“Over-exposure to sunlight can increase the risk of skin cancer, skin aging, immune suppression and eye damage. But under-exposure to sunlight can lead to vitamin D deficiency – a major risk factor for bone diseases, diabetes, depression, some common cancers and cardiovascular diseases,” said Nattapon Chaimanonart, Ultra CEO. “Violet helps people achieve the optimal balance of sun exposure.”

Kickstarter campaigns operate under an “all-or-nothing” funding model so Violet must reach its goal of $100,000 to kick-off product development. For more information and the latest product updates, follow Violet on Twitter and Facebook.

About Ultra
Ultra, Inc. provides innovative mobile health solutions that empower people to “live ultra healthy” by integrating cutting-edge sensor technology, wearable computing, and cloud services which monitor and analyze environmental conditions and its impact on a healthy lifestyle. Corporate headquarters are located in Portland, Oregon.


Read the full story at

Source: PRWeb
Copyright©2014 Vocus, Inc.
All rights reserved

Related medicine news :

1. Daily Aspirin May Help Prevent Cancer, Study Shows
2. Nourish Skin With Entirely Natural Daily Body Oil from Sublime Beauty® On Sale Now
3. How to Reach the Heart of the Perfect Guy with "Enchant Him Program" - a Report by Daily Gossip Magazine
4. Our daily bread
5. Most Kids Eat Fruit, Veggies Daily: CDC
6. Individual brain activity predicts tendency to succumb to daily temptations
7. Long-term daily multivitamin supplement use decreases cataract risk in men
8. Daily walk of just 3km can reduce risk of hospitalization for respiratory problems
9. Daily Multivitamin Without Iron Available on Amazon From EverSun Health Helps People Fight Sickness During Flu Season
10. Onnit Releases All-In-One Daily Greens Drink Mix
11. Daily Low-dose Aspirin Can Prevent Heart Attack and Stroke But is Often Misused, from the January 2014 Harvard Heart Letter
Post Your Comments:
(Date:11/25/2015)... ... November 25, 2015 , ... “While riding the bus, I ... Bronx, N.Y. “I thought there had to be a convenient and comfortable way to ... The PROTECTOR enables disabled individuals to safely travel during cold or inclement weather. In ...
(Date:11/25/2015)... , ... November 25, 2015 , ... ... (PHA) announces the nation’s Periwinkle Pioneers, individuals and groups responsible for advancing care ... disease. The Periwinkle Pioneers, nominated by the public, will receive special recognition throughout ...
(Date:11/25/2015)... ... November 25, 2015 , ... ... philanthropic seniors, is resulting in a way for homeless people to have a ... have launched a new initiative whereby they are repurposing plastic bags into sleeping ...
(Date:11/25/2015)... ... November 25, 2015 , ... Since its launch in 2012, ... adult stem cell therapies to patients with chronic degenerative medical conditions. Now, the ... Registered Trademark (RTM). , Organizations are required to hold a registered trademark in ...
(Date:11/24/2015)... ... November 25, 2015 , ... Genesis Chiropractic Software ... software creates an agreement between the practice owner and the patient that automatically ... notification, and projections. Click here to learn more. , ...
Breaking Medicine News(10 mins):
(Date:11/24/2015)... FRANCISCO , Nov. 24, 2015  Thanks to ... Dignity Health St. Mary,s Medical Center,s Sister Diane Grassilli ... breast imaging capabilities in San Francisco ... an anonymous friend, stepped forward with a gift of ... for Breast Digital Mammography with Tomosynthesis and Whole Breast ...
(Date:11/24/2015)... Colo. , Nov. 24, 2015  Array ... that its Chief Executive Officer, Ron Squarer ... Healthcare Conference in New York.  The public is ... webcast on the Array BioPharma website.Event:Piper Jaffray Annual ... , Wednesday, December 2, 2015Time:1:30 p.m. Eastern Time ...
(Date:11/24/2015)... HOUSTON, TX and VANCOUVER, Nov. 24, 2015 /PRNewswire/ ... EPI; NASDAQ: EPIX ) announced today that the ... clinical study of EPI-506 as a treatment for metastatic ... States and Canada.  --> ... --> In the Phase 1/2 clinical trial, ...
Breaking Medicine Technology: